Description
Semax 10 mg — Opti-Gen Peptides
For laboratory research use only.
Not for human use. Not for veterinary use.
Not licensed by the MHRA. Not a medicinal product on this listing.
Research-grade synthetic heptapeptide supplied as a 10 mg sealed vial for lawful laboratory research in the UK. Not a food, supplement or medical device. Not for diagnostic or therapeutic use. Must not be administered to people or animals.
Semax is authorised as a medicine in some countries. Those authorisations do not apply to this research vial and do not make it a UK medicine.
Identification
| Product name | Semax |
| Research description | ACTH(4–7) analogue with Pro-Gly-Pro C-terminus |
| Supplier | Opti-Gen Peptides |
| Contents | 10 mg per vial |
| Sequence | Met-Glu-His-Phe-Pro-Gly-Pro |
| CAS | 80714-61-0 |
| Formula | C₃₇H₅₁N₉O₁₀S |
| Approx. mass | ~814 Da |
| Class | Synthetic heptapeptide |
| Intended use | Laboratory / in-vitro research only |
Not Selank.
Quality / storage
Only the lot COA applies. Store as a laboratory chemical under institutional SOP. No preparation, nasal, or injection instructions on this page.
Published research context (not product claims)
Semax was developed from ACTH fragment chemistry. Papers describe melanocortin-related peptide work and experimental studies of CNS signalling, neurotrophin expression and ischaemia models. Russian clinical literature exists for authorised local products. That literature does not authorise sale or advertising of this vial as a nootropic, stroke or cognitive medicine in the UK.
UK notice
18+. Buyer confirms lawful laboratory research use only and will not use or resell for unauthorised human or animal use.
Reviews
There are no reviews yet.